Confirmatory Western Blot tests are labor-intensive, expensive, and consume valuable lab and administrative resources. By eliminating 90 percent of false positive ELISA results, the C6 Lyme ELISA eliminates the cost of the unnecessary Western Blot tests. This significantly reduces the average cost per reportable patient result.